AVR anteris technologies global corp.
Add to My Watchlist 3.43% ! $5.91

FDA submission for early feasibility study, page-2

  1. MactavishNat
    430 Posts.
    lightbulb Created with Sketch. 133
    clock Created with Sketch.
    24/02/22
    18:45
    Post #: 59802029
    the last I heard was the market will be updated once FDA approval is secured for the trial, could be any day now as they would have used the 30 day data from the first 5 patients from Georgia in the final dossier.
    AVR Price at posting: $17.46 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Red Mountain to map, sample Quartz Reef after landing big alluvial nugget haul
right-arrow Created with Sketch.
NEWS Profits after tax down -88%, and shares rocket – what's going on with Collins?
right-arrow Created with Sketch.
NUZ Liquid Formulation of NUZ-001 Developed to Improve Patient Access and Experience
right-arrow Created with Sketch.
NEWS Many Peaks accelerating gold hunt in Côte d'Ivoire after assay 'justification'
right-arrow Created with Sketch.
NEWS Uranium ignites: Is this the start of a supercycle?
right-arrow Created with Sketch.
NEWS Sparc opens small-scale green H2 plant in SA, but liquidity dried up
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.91 		Change
-0.210(3.43%) 		Mkt cap ! $91.59M
Open High Low Value Volume
$6.01 $6.08 $5.85 $44.71K 7.43K

Buyers (Bids)

No. Vol. Price($)
1 857 $5.83
 

Sellers (Offers)

Price($) Vol. No.
$6.08 260 1
View Market Depth
Last trade - 15.51pm 26/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.